Product Information
METHYLPREDNISOLONE 4 MG DOSEPK is a generic product labeled by BluePoint Laboratories, priced at $0.1361 per EA under NDC 68001062401. Its NADAC has been published 66 times since Jul 2, 2025.
FDA first approved this application on Apr 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001062401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPREDNISOLONEApproval Type
Generic (ANDA)
FDA Application
ANDA206751FDA Approved
4/23/2018
TE Code
AB
On Market Since
5/1/2025
Pharmacological Classes
Price Statistics
The NADAC for METHYLPREDNISOLONE 4 MG DOSEPK has been published 66 times since Jul 2, 2025, and over the history we have for it it has risen 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1361 per EA |
|---|---|
| All-time high | $0.1361 (Sep 30, 2026) |
| All-time low | $0.1124 (Jun 17, 2026) |
| 52-week high | $0.1361 |
| 52-week low | $0.1124 |
| Median price | $0.1164 |
| Average price | $0.1202 |
| Largest weekly change | +8.4% (Aug 19, 2026) |
| Weeks tracked | 66 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methylprednisolone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPREDNISOLONE 4 MG DOSEPK?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 4 MG DOSEPK, manufactured by BluePoint Laboratories, is $0.1361 per EA (NDC 68001062401), effective Sep 30, 2026.
How has the price of METHYLPREDNISOLONE 4 MG DOSEPK changed over time?
Over the history we have for it, the NADAC for METHYLPREDNISOLONE 4 MG DOSEPK has risen 2.9%. It has been tracked across 66 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 4 MG DOSEPK?
Since Jul 2, 2025, the NADAC for METHYLPREDNISOLONE 4 MG DOSEPK has ranged from a low of $0.1124 (Jun 17, 2026) to a high of $0.1361 (Sep 30, 2026), with a median of $0.1164 per EA.
Are there cheaper alternatives to METHYLPREDNISOLONE 4 MG DOSEPK?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPREDNISOLONE 4 MG TABLET, is $0.1211 per EA — about 11% below METHYLPREDNISOLONE 4 MG DOSEPK.
Who manufactures METHYLPREDNISOLONE 4 MG DOSEPK?
METHYLPREDNISOLONE 4 MG DOSEPK (NDC 68001062401) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.